Pakistan Pharmas Call For 20 Percent Increase In Allowed Drug Prices
This article was originally published in PharmAsia News
Executive Summary
The Pakistan Pharmaceutical Manufacturers Association is calling for a 20 percent increase in the allowed prices for drugs in the country. The industry cites added costs of raw materials and energy as well as the devalued Pakistani currency as reasons for allowing a price hike. The group said lifting the cap on drug prices was essential if the nation's drug-making industry is to survive. The PPMA estimated lifting the caps would save Pakistan the $3 billion cost of importing foreign-made drugs that comprise more than 90 percent of drugs available in the country. (Click here for more